Literature DB >> 9572677

Different effects of opiate withdrawal on dopamine turnover, uptake, and release in the striatum and nucleus accumbens.

S Ghosh1, A H Patel, M Cousins, K Grasing.   

Abstract

The purpose of these experiments was to further characterize changes in dopaminergic function that follow withdrawal from chronic opiate treatment. Withdrawal after treatment to a maximum dose of 120 mg/kg of morphine did not alter dopamine concentrations in the substantia nigra, ventral tegmental area, striatum, or nucleus accumbens; but did decrease concentrations of DOPAC and the ratio of DOPAC to dopamine in the lateral striatum and nucleus accumbens. Uptake of tritiated dopamine was diminished for withdrawn slices obtained from the striatum with no effect observed for tissue from the nucleus accumbens. Deficits of in vitro release of tritiated dopamine also occurred following withdrawal, with the nucleus accumbens being sensitive to dependence produced by a lower dose of morphine. In conclusion, opiate withdrawal produces a complex pattern of effects on dopaminergic function that is specific for the striatum and nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572677     DOI: 10.1023/a:1022463029351

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  47 in total

1.  Opiate-receptor mediated changes in monoamine synthesis in rat brain.

Authors:  J A Garcia-Sevilla; L Ahtee; T Magnusson; A Carlsson
Journal:  J Pharm Pharmacol       Date:  1978-10       Impact factor: 3.765

Review 2.  A psychomotor stimulant theory of addiction.

Authors:  R A Wise; M A Bozarth
Journal:  Psychol Rev       Date:  1987-10       Impact factor: 8.934

3.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.

Authors:  R H Roth; L C Murrin; J R Walters
Journal:  Eur J Pharmacol       Date:  1976-03       Impact factor: 4.432

4.  Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

5.  Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex.

Authors:  E D Abercrombie; K A Keefe; D S DiFrischia; M J Zigmond
Journal:  J Neurochem       Date:  1989-05       Impact factor: 5.372

6.  Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.

Authors:  T S Shippenberg; R Bals-Kubik; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

7.  Intranigral GR-113808, a selective 5-HT4 receptor antagonist, attenuates morphine-stimulated dopamine release in the rat striatum.

Authors:  L Pozzi; L Trabace; R Invernizzi; R Samanin
Journal:  Brain Res       Date:  1995-09-18       Impact factor: 3.252

8.  Effects of 4-aminopyridine on calcium action potentials and calcium current under voltage clamp in spinal neurons.

Authors:  M A Rogawski; J L Barker
Journal:  Brain Res       Date:  1983-11-28       Impact factor: 3.252

9.  Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment.

Authors:  E Pothos; P Rada; G P Mark; B G Hoebel
Journal:  Brain Res       Date:  1991-12-06       Impact factor: 3.252

10.  Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation.

Authors:  G H Tjon; T J De Vries; E Ronken; F Hogenboom; G Wardeh; A H Mulder; A N Schoffelmeer
Journal:  Eur J Pharmacol       Date:  1994-02-03       Impact factor: 4.432

View more
  2 in total

1.  Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal.

Authors:  S Ghosh; K Grasing
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

2.  Altered Accumbal Dopamine Terminal Dynamics Following Chronic Heroin Self-Administration.

Authors:  Brianna E George; Monica H Dawes; Emily G Peck; Sara R Jones
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.